Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People diagnosed with obstructive hypertrophic cardiomyopathy (a condition where the heart muscle is thickened and blocks blood flow) according to specific 2023 medical guidelines
- People who already have a cardiac MRI scan with a special type of heart blood flow imaging (called myocardial perfusion) planned as part of their regular medical care
- People currently being treated with the standard recommended medications for their condition
- People willing and able to attend follow-up appointments that include scans and tests
- People willing to sign a written consent form agreeing to take part
Who may not be able to join:
- People who experience severe fear of enclosed spaces (claustrophobia) or have any other medical reason that makes having an MRI scan unsafe
- People with significant narrowing or blockage of the heart's own blood vessels, or who have previously had a heart stent or bypass surgery
- People who have experienced a cardiac arrest or a serious irregular heart rhythm in the 12 months before the screening assessment
- People with significantly reduced kidney function (confirm with trial site)
- People with significant liver problems, including markedly elevated liver blood test results or liver cirrhosis
- People with a known allergy to MRI contrast dye
- People whose thickened heart muscle is caused by a different underlying condition, such as cardiac amyloidosis or Fabry disease, rather than hypertrophic cardiomyopathy
- Women who are currently pregnant, or women of childbearing age who wish to become pregnant
- Women who are currently breastfeeding
- People who are unwilling to follow the study procedures and requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation between myocardial perfusion reserve changes and changes in the performed distance in 6MWT.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.